Wishlist
Cart
Sort by:

You're viewing 9 of 9 products

Aclaris Therapeutics – Innovating Immuno-Dermatology

Aclaris Therapeutics, Inc. is a clinical-stage biotechnology company based in the United States. It focuses on creating targeted therapies for immune-inflammatory diseases, particularly those affecting the skin. Leveraging its proprietary drug discovery platform, the company develops advanced kinase inhibitors and monoclonal antibodies for conditions with limited treatment options.

Core Areas of Innovation

Aclaris specializes in immuno-dermatology and inflammation, developing both oral and topical treatments. Their proprietary research platform enables the identification of new drug candidates that selectively target disease-related kinases without affecting healthy tissues.

1. Small Molecule Inhibitors

These orally or topically administered drugs are designed to block specific enzymes (kinases) responsible for inflammation in diseases like atopic dermatitis, alopecia areata, and more.

2. Biologic Therapies

The company is also advancing antibody-based treatments to interrupt immune pathways responsible for chronic skin conditions and systemic inflammation.

Product Pipeline Highlights

  • ATI-2138: An oral therapy in development for eczema and related disorders.

  • ATI-1777: A topical formulation intended for localized skin inflammation.

  • ATI-450: An oral MK2 inhibitor being evaluated in oncology and immune conditions.

  • ATI-045 & ATI-052: Next-generation antibody treatments with potential applications in dermatology and beyond.

These therapies are at various stages of clinical trials, aiming to provide targeted relief with fewer side effects.

Strategic Collaborations

Aclaris has partnered with leading pharmaceutical companies to expand the reach and development of select therapies, especially for conditions like hair loss and autoimmune skin diseases. These collaborations support the company’s research and allow it to maintain a strong pipeline while managing risk.

Aclaris Therapeutics continues to be a forward-thinking force in the biotech world, working to deliver effective, science-driven treatments for challenging skin and immune conditions.

To top